#gene mutation

Two new clinical trials compare Retevmo (selpercatinib) with other standard treatments for tumors with changes in the RET gene.

The Invitae test analyzes a person’s blood sample for changes in 47 genes that are linked to hereditary forms of cancer.

Scientists built a dataset with genomic, proteomic, and clinical data from more than 1,000 tumors across 10 cancer types.

The FDA approved Vanflyta (quizartinib) with chemotherapy for FLT3-mutated AML, an aggressive type of blood cancer.

Learn more about melanoma risk factors, hereditary melanoma, and genetic testing.

Measurable traits, such as genetic mutations, can guide treatment and help predict outcomes.

I’ve never written a summary of my lung cancer journey like this before, explains blogger and author Dann Wonser in his latest post.

Osimertinib led to a 51% improvement in survival, but some say the placebo group did not receive adequate treatment.

Researchers found a new way to detect cancer risk by looking for a signal in the blood, not for the presence of BRCA gene mutations.

People with mutations that lead to excessively long chromosome tips, or telomeres, may be at increased risk for a range of cancers.

Understanding cancer DNA evolution is key to developing targeted therapies.

CU Cancer Center researchers spotlight how p53, the most frequently mutated tumor suppressor gene, can be activated against cancer cells.

His cancer has returned, but Dann Wonser gets into a clinical trial for a med proven effective for his mutation (EGFR exon 19).

Watch these videos to learn how the Prostate Cancer Promise registry aims to identify hereditary DNA mutations.

Promising research shows that marking the mutated KRAS protein of cancer cells can signal the immune system to destroy that cancer.

Is DNA fate? Are cell mutations really the cause of cancer? A Fred Hutch skin cancer and stem cell scientist poses other possibilities.